The Food and Drug Administration (FDA) announces a public workshop, Biofilms, Medical Devices and Anti-Biofilm Technology Challenges and Opportunities." FDA is co-sponsoring this workshop with the Center for Biofilm Engineering (CBE) of Montana State University.
Â
The biochemical and physiochemical characteristics of biofilms have been studied in-vitro, but the role that biofilms play in the development of device-related and other healthcare-associated infections, and their connection with development of resistant infections has been less widely studied until recent years, where research is increasingly making great strides.
Â
With the increasing use of implanted and indwelling devices, understanding biofilm development on these devices and factors that impact biofilm formation is critical for protecting/promoting public health. Research on the basic science of biofilms may provide insight on device-associated biofilms, ultimately advancing research on technologies that are intended to prevent biofilm formation.
Â
This public workshop seeks to share scientific information between the academic and healthcare communities, industry interested in developing products to address biofilm contamination, and U.S. government scientists.
Â
Major topics to be covered at this workshop are:
1. Research on biofilms and their public health impact
2. Challenges faced by the scientific community, clinical community, government, and industry on addressing biofilm contamination of medical devices
3. Critical areas of research that will address the scientific and clinical challenges faced by the stakeholders when developing technologies that are intended to prevent biofilm formation.
Â
This public workshop may also form the basis for future discussions related to novel biofilm prevention technologies that could benefit U.S. public health.
 Â
This meeting will be held on Feb. 20, 2014, beginning at 8 a.m. at the FDA's White Oak Campus, 10903 New Hampshire Ave. , Bldg. 31, Room 1503, in Silver Spring, Md.
For more details, visit: http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm381336.htm
Source: FDA
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.